Hinge Health, Inc. (HNGE) stock
Close on Oct 30, 2026Market cap $9.22BP/E –Yield –
Earnings
Hinge Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Hinge Health's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 3, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jun 30, 2026 | Aug 4, 2026after the close | $212.80M | +53.0% | $0.52 | $0.59 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026after the close | $182.30M | – | $0.41 | $0.45 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 10, 2026after the close | $170.70M | – | $0.37 | $0.49 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025after the close | $154.20M | – | -$0.02 | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 5, 2025after the close | $139.10M | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Hinge Health's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenue | Q3 FY2026 | $223.00M – $225.00M | – | New | Aug 4, 2026 |
| non-GAAP income from operationsnon-GAAP | Q3 FY2026 | $61.00M – $63.00M | – | New | Aug 4, 2026 |
| revenue guidance | FY2026 | $856.00M – $860.00M | $798.00M – $804.00M | Raised | Aug 4, 2026 |
| year over year growth | FY2026 | +25% | – | New | Feb 10, 2026 |
| non-GAAP income from operations guidancenon-GAAP | FY2026 | $236.00M – $244.00M | $205.00M – $215.00M | Raised | Aug 4, 2026 |
| year over year growthnon-GAAP | FY2026 | +29% | – | New | Feb 10, 2026 |
| non-GAAP operating marginnon-GAAP | FY2026 | 26% | 21% | Raised | May 5, 2026 |
Guidance vs results
The last range Hinge Health gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Revenue | $194.00M – $196.00M | $212.80M | Above range |
| Q1 FY2026 | Revenue | $171.00M – $173.00M | $182.30M | Above range |
| Q4 FY2025 | Revenue | $155.00M – $157.00M | $170.70M | Above range |
| Q3 FY2025 | Revenue | $141.00M – $143.00M | $154.20M | Above range |
Guidance history
Every forecast Hinge Health put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 4, 2026 | non-GAAP income from operations guidance | FY2026 | $236.00M – $244.00M | Raised |
| Aug 4, 2026 | non-GAAP income from operations | Q3 FY2026 | $61.00M – $63.00M | New |
| Aug 4, 2026 | revenue guidance | FY2026 | $856.00M – $860.00M | Raised |
| Aug 4, 2026 | revenue | Q3 FY2026 | $223.00M – $225.00M | New |
| May 5, 2026 | non-GAAP income from operations | FY2026 | $205.00M – $215.00M | Raised |
| May 5, 2026 | non-GAAP income from operations | Q2 FY2026 | $47.00M – $49.00M | New |
| May 5, 2026 | non-GAAP operating margin | FY2026 | 26% | Raised |
| May 5, 2026 | non-GAAP operating margin | Q2 FY2026 | 25% | New |
| May 5, 2026 | revenue | FY2026 | $798.00M – $804.00M | Raised |
| May 5, 2026 | revenue | Q2 FY2026 | $194.00M – $196.00M | New |
| Feb 10, 2026 | year over year growth | FY2026 | +29% | New |
| Feb 10, 2026 | non-GAAP income from operations | FY2026 | $151.00M – $156.00M | New |
| Feb 10, 2026 | year over year growth | Q1 FY2026 | +108% | New |
| Feb 10, 2026 | non-GAAP income from operations | Q1 FY2026 | $30.00M – $32.00M | New |
| Feb 10, 2026 | non-GAAP operating margin | FY2026 | 21% | New |
| Feb 10, 2026 | non-GAAP operating margin | Q1 FY2026 | 18% | New |
| Feb 10, 2026 | year over year growth | FY2026 | +25% | New |
| Feb 10, 2026 | revenue | FY2026 | $732.00M – $742.00M | New |
| Feb 10, 2026 | year over year growth | Q1 FY2026 | +39% | New |
| Feb 10, 2026 | revenue | Q1 FY2026 | $171.00M – $173.00M | New |
| Nov 4, 2025 | non-GAAP income from operations guidance | FY2025 | 106% – 108% | New |
| Nov 4, 2025 | non-GAAP income from operations | Q4 FY2025 | $34.00M – $36.00M | New |
| Nov 4, 2025 | non-GAAP operating margin | FY2025 | 19% | New |
| Nov 4, 2025 | non-GAAP operating margin | Q4 FY2025 | 22% | New |
| Nov 4, 2025 | year-over-year growth | Q4 FY2025 | +63% | New |
| Nov 4, 2025 | year-over-year growth | FY2025 | +47% | New |
| Nov 4, 2025 | revenue guidance | FY2025 | $572.00M – $574.00M | New |
| Nov 4, 2025 | year-over-year growth | Q4 FY2025 | +33% | New |
| Nov 4, 2025 | revenue | Q4 FY2025 | $155.00M – $157.00M | New |
| Aug 5, 2025 | non-GAAP income from operations | Q3 FY2025 | $17.00M – $21.00M | New |
| Aug 5, 2025 | non-GAAP income from operations | FY2025 | $77.00M – $83.00M | New |
| Aug 5, 2025 | revenue | Q3 FY2025 | $141.00M – $143.00M | New |
| Aug 5, 2025 | revenue | FY2025 | $548.00M – $552.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Hinge Health filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results